title: The (Ala-Val) mutation of methylenetetrahydrofolate reductase as a genetic risk factor for vascular disease in non-insulin-dependent diabetic patients.
authors.forename: M C
authors.initials: MC
authors.lastname: Brulhart
authors.forename: P
authors.initials: P
authors.lastname: Dussoix
authors.forename: J
authors.initials: J
authors.lastname: Ruiz
authors.forename: P
authors.initials: P
authors.lastname: Passa
authors.forename: P
authors.initials: P
authors.lastname: Froguel
authors.forename: R W
authors.initials: RW
authors.lastname: James
mesh_terms: D003327:Coronary Disease / Q000150:complications / Q000235:genetics*; D003924:Diabetes Mellitus, Type 2 / Q000201:enzymology / Q000235:genetics*; D003925:Diabetic Angiopathies / Q000201:enzymology / Q000235:genetics*; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D000587:Oxidoreductases Acting on CH-NH Group Donors / Q000235:genetics*; D017354:Point Mutation; D012307:Risk Factors
chemical_list: D000587:Oxidoreductases Acting on CH-NH Group Donors; D042965:Methylenetetrahydrofolate Reductase (NADPH2)